Friday, December 6, 2019
Home »
» Medical News Today: How to treat and prevent leg muscle cramps
Medical News Today: How to treat and prevent leg muscle cramps
Leg muscle cramps are common, but they can be uncomfortable and very painful. In this article, learn about how to treat and prevent them.
Related Posts:
10th annual hepatitis conference to be held July 27 in Lexington By Melissa Patrick Kentucky Health News Kentucky, which has one of the nation's highest rates of hepatitis C infection, will hold its 10th annual Viral Hepatitis Conference next week, on the day before World Hepatitis Day. T… Read More
Opioid commission, with new member, will hold hearing Monday, July 17 on ibogaine, exotic drug proposed for drug treatmentBy Melissa Patrick Kentucky Health News The Kentucky Opioid Abatement Advisory Commission will hold its first public hearing Monday, July 17, about the use of an exotic psychedelic drug, ibogaine, as a treatment for opioid-us… Read More
Judge reverses his ruling that blocked law on gender-affirming care, citing 2-1 ruling of appeals court handling similar casesBy Sarah LaddKentucky Lantern A federal judge on Friday stayed a temporary block on part of a new Kentucky law that banned gender-affirming medical care for transgender minors. That means Kentucky’s transgender children are… Read More
In the first two months of resumed checks for Medicaid eligibility, almost half of Ky. members up for renewal lost their coverage By Melissa Patrick Kentucky Health News The end of the pandemic meant resumption of eligibility verification for Medicaid, and almost half of the Kentuckians who have been asked to renew their Medicaid coverage in the firs… Read More
Advocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study The Opioid Abatement Advisory Commission held its first public hearing July 17, in Frankfort, to hear about use of the psychedelic drug ibogaine for treatment of opioid-use disorder. (Photo by Melissa Patrick) By Mel… Read More
0 comments:
Post a Comment